AUPH - Aurinia Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts4266
Avg. Estimate-0.15-0.19-1.03-0.55
Low Estimate-0.19-0.2-1.19-0.87
High Estimate-0.08-0.18-0.860.28
Year Ago EPS-0.22-0.92-0.66-1.03
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts4255
Avg. Estimate50k30k420k13.19M
Low Estimate30k30k400k110k
High Estimate100k30k420k65.18M
Year Ago Sales30k31k173k420k
Sales Growth (year/est)66.70%-3.20%142.80%3,040.50%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.12-0.12-0.12-0.15
EPS Actual-0.22-0.92-0.03-0.16
Difference-0.1-0.80.09-0.01
Surprise %-83.30%-666.70%75.00%-6.70%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.15-0.19-1.03-0.55
7 Days Ago-0.15-0.19-1.03-0.55
30 Days Ago-0.11-0.16-0.98-0.44
60 Days Ago-0.11-0.16-1.01-0.39
90 Days Ago-0.14-0.16-0.94-0.63
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesAUPHIndustrySectorS&P 500
Current Qtr.31.80%N/AN/A0.22
Next Qtr.79.30%N/AN/A0.25
Current Year-56.10%N/AN/A0.08
Next Year46.60%N/AN/A0.12
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A